Research
Size:
Share:

FAME - Sponsored by Alimera Sciences

Completed Study | Duration: 36 months

IluvienĀ® is an extended release intravitreal insert developed for the treatment of Diabetic Macular Edema. During the trial, IluvienĀ® demonstrated a significant effect on improving vision and reducing edema at week three. This effect was maintained throughout the 36 months of the trial.

Return to Diabetic Retinopathy